This is a demo store. No orders will be fulfilled.

Protease Inhibitors

Proteases are widely present in cells and play a critical role in protein degradation and homeostasis regulation. However, during biochemical and molecular biology experiments, samples are susceptible to degradation by endogenous proteases during lysis or purification, which can lead to loss or functional impairment of target proteins. To prevent this, researchers typically add protease inhibitors to the lysis buffer to maintain sample integrity.

Ⅰ. Classification of Protease Inhibitors

Due to the diversity of proteases, there is no “universal” inhibitor. In practice, multiple inhibitors are often combined based on sample characteristics. Common inhibitors can be classified according to their targets:

1.Serine Protease Inhibitors

Targets: Trypsin, chymotrypsin, thrombin, and other serine proteases.

Representative Inhibitors:

  • PMSF (Phenylmethylsulfonyl fluoride): A classic inhibitor with high efficiency, but extremely unstable in aqueous solution (half-life ~30 minutes), and should be added immediately before use.
  • AEBSF (4-(2-Aminoethyl)benzenesulfonyl fluoride): Water-soluble with better stability and safety than PMSF.
  • Aprotinin: A small protein that reversibly inhibits multiple serine proteases.

Name

ID

Grade & Purity

PMSF Solution

P301906

100mM in ethanol

Phenylmethanesulfonyl fluoride

P105539

Moligand™, ≥98%(GC)

PMSF

P408676

10mM in DMSO

4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride

A423184

10mM in DMSO

AEBSF Solution

A301905

50mg/ml in H2O

AEBSF Solution

A301913

10mg/ml in H2O

4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride

A109762

≥98%

Recombinant Aprotinin

R426862

EnzymoPure™, 10mM in Water

Aprotinin bovine

A755622

Recombinant, ≥98%(SDS-PAGE), expressed in Nicotiana(tobacco),≥5 TIU/mg protein

Aprotinin from bovine lung

A755682

UltraBio™, ≥98%(SDS-PAGE), 3-8 TIU/mg solid

Aprotinin

A274384

EnzymoPure™, High-purity

Recombinant Aprotinin

R141091

EnzymoPure™, ≥3 EPU/mg

Aprotinin from bovine lung

A105534

EnzymoPure™, 3-8 TIU/mg

2. Cysteine Protease Inhibitors

Targets: Cathepsins, such as Cathepsin B and L.

Representative Inhibitors:

  • E64: Highly efficient, specific, irreversible, and stable.
  • Leupeptin: A reversible inhibitor that also exhibits activity against some serine proteases.


Figure 1. Chemical structure of E-64

Name

ID

Grade & Purity

E-64

E425359

10mM in DMSO

E-64

E109034

Moligand™, ≥99%, protease inhibitor

Leupeptin

L420424

EnzymoPure™, 10mM in DMSO

Leupeptin

L755635

UltraBio™, ≥95%(HPLC), microbial

Leupeptin hemisulfate salt

L111765

Moligand™, ≥90%(HPLC)

Leupeptin

L274378

High-purity, EnzymoPure™

3. Aspartic Protease Inhibitors

Targets: Pepsin, Cathepsin D, renin.

Representative Inhibitor:

  • Pepstatin A: Highly specific and effective at low concentrations, but poorly soluble; typically prepared in methanol or ethanol.

Name

ID

Grade & Purity

Pepstatin

P113168

Moligand™, ≥75%(HPLC)

Pepstatin

P422930

10mM in DMSO

Pepstatin A TFA

P359425

≥97%

4.Metalloprotease Inhibitors

Targets: Collagenases, thermolysin, and other Zn²⁺-dependent proteases.

Representative Inhibitors:

  • EDTA / EGTA: Act by chelating metal ions; broad-spectrum and commonly used.
  • 1,10-Phenanthroline: Also inhibits enzyme activity through metal ion chelation.


Figure 2. Chemical structure of EGTA

Name

ID

Grade & Purity

EDTA disodium salt concentrate

E299201

Diluted to 1 liters, the diluted concentration was 0.1M

EDTA disodium salt concentrate

E197261

Diluted to 1 liters, the diluted concentration was 0.01M

Ethylenediaminetetraacetic acid disodium salt dihydrate

E433190

UltraBio™, Ultra pure, ≥98.5%

Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA)

E104432

AR, ≥99%

Ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid

E104434

Suitable for molecular biology, ≥99%

1,10-Phenanthroline Monohydrate

P424421

10mM in DMSO

1,10-Phenanthroline Monohydrate

P104935

ACS, ≥99%

1,10-Phenanthroline Monohydrate

P104932

AR, ≥98%

5.Aminopeptidase Inhibitors

Targets: Proteases that sequentially cleave amino acids from the N-terminus of peptide chains.

Representative Inhibitors:

  • Bestatin: Effective against aminopeptidase B and leucine aminopeptidase.
  • EDTA: Also inhibits metal-dependent aminopeptidases.

Name

ID

Grade & Purity

Bestatin hydrochloride

B117660

≥98%(HPLC)

6.Proteasome Inhibitors

Targets: The 26S proteasome complex.

Representative Inhibitors:

  • MG132: A reversible inhibitor commonly used to study the ubiquitin–proteasome pathway.
  • Lactacystin: Irreversible and highly specific.


Figure3. Chemical structure of MG-132

Name

ID

Grade & Purity

MG-132

M126521

Moligand™, ≥98%

Lactacystin

L769926

BioReagent, ≥95%

II. Usage Strategies

1. Principle of Combined Use

Tissue and cell samples often contain multiple types of proteases. Therefore, it is recommended to use a mixture of inhibitors rather than a single inhibitor to achieve broad-spectrum protection.

2. Sources and Preparation

  • Commercially available inhibitor cocktails: Typically provided as tablets or ready-to-use solutions, with optimized ratios. Convenient for routine experiments.
  • Custom preparation: Inhibitors can be combined according to experimental needs. Below is a basic formulation for protein extraction from mammalian cells or tissues (working concentrations for reference only).

Inhibitor

Working Concentration

Target Protease Type

Stock Solution (Solvent)

Storage Condition

Catalog Number

PMSF

1 mM

Serine proteases

100 mM (ethanol / isopropanol)

–20 °C, protected from light

P105539

Aprotinin

0.31 μM

Serine proteases

1 mg/mL (deionized water)

–20 °C, aliquoted

A274384

Leupeptin

0.5 μg/mL

Cysteine + Serine proteases

1 mg/mL (deionized water)

–20 °C, aliquoted

L274378

Pepstatin A

1 μM

Aspartic proteases

1 mg/mL (methanol / ethanol)

–20 °C, protected from light

P113168

EDTA

0.5 mM

Metalloproteases

0.5 M (deionized water, pH adjusted to 8.0)

Room temperature

E433190

Note:PMSF must be freshly added before use. Stock solutions should be aliquoted and stored at –20 °C.

III. Experimental Considerations

1.Low-temperature handling: Perform all steps on ice to reduce protease activity.

2.Pre-addition of inhibitors: Add inhibitors to the lysis buffer before use to ensure immediate protection of the sample.

3.Concentration control: Avoid excessive use, as this may interfere with downstream experiments (e.g., immunoprecipitation, functional assays).

4.Stability differences: Some inhibitors (e.g., PMSF) must be used quickly to prevent inactivation.

5.Special requirements: For studies involving phosphorylated proteins, additional phosphatase inhibitors (e.g., NaF, β-glycerophosphate, Na₃VO₄) should be included.

6.Safety precautions: Many inhibitors are toxic; handle them in a fume hood and wear appropriate protective equipment.

 

Aladdin: https://www.aladdinsci.com/

Categories: 技术文章